Alzheimer's Disease: The Brand
  • Why Alzheimer's Disease?
  • Curating and Creating
  • Alzheimer's Disease: The Brand...the book!
Keep tabs on the journey...
UA-62070106-1

Let's focus more on the data, and less on the donut...

8/8/2015

 
Picture
My dad had Alzheimer's disease. My family bore witness to the limitations of managing an aging parent with AD as we quietly wondered if our final years would be less tarnished--more golden. The rush to identify diagnostic biomarkers for early treatment or cures that haven't materialized seems counterproductive or at least aspirant. 

There is real data that suggests meaningful correlations between social determinants of health and risk of chronic diseases in old age such as diabetes and Alzheimer's disease. I would like to see more research focused here for the societal benefit as well as real actionable behaviors toward prevention.

Social determinants of health are conditions in the environments in which people are born, live, learn, work, play, worship, and age that affect a wide range of health, functioning, and quality-of-life outcomes and risks. Conditions (e.g., social, economic, and physical) in these various environments and settings (e.g., school, church, workplace, and neighborhood) have been referred to as “place.”5 In addition to the more material attributes of “place,” the patterns of social engagement and sense of security and well-being are also affected by where people live. Resources that enhance quality of life can have a significant influence on population health outcomes. Examples of these resources include safe and affordable housing, access to education, public safety, availability of healthy foods, local emergency/health services, and environments free of life-threatening toxins--Healthypeople.gov
Willette and colleagues examined insulin signaling impairment in late middle-aged participants at risk for AD. Details of the population-based, cross-sectional study (n=150) can be found here. The important key take-away is higher peripheral insulin resistance (HOMA-IR) was associated with lower cerebral glucose metabolism. Lower glucose metabolism was correlated with worse performance on immediate memory and delayed memory factor scores--"midlife may be a critical period for initiating treatments to lower peripheral insulin resistance to maintain neural metabolism and cognitive function."--JAMA Neurology

Association of Insulin-Resistance with Cerebral Glucose Uptake in Late Middle-Aged Adults at Risk for Alzheimer Disease

Peripheral insulin resistance has been characterized as having an active role in the brain and correlated with higher risk for AD. A voxel is a 3-dimensional pixel, HOMA-IR, APOE e4 genotype, and parental AD history were used to investigate glucose metabolism in temporal, parietal, and frontal regions of the brain.
Picture
The prevalence of AD continues to grow, and midlifemay be a critical period for initiating treatments aimed at preventing or delaying the onset of AD. Accumulating evidence suggests that treatments targeting mechanisms involved in insulin signaling may affect central glucose metabolism and should be investigated in the context of presymptomatic AD.--JAMA Neurology

Both diabetes type 2 and Alzheimer's disease are characterized by mitochnodrial vulnerability and dysfunction. We do know that correlation is not causation but it is interesting that in this current study, HOMA-IR predicted the rate of glucose metabolism "more strongly" than APOE e4 genotype. Ongoing research may clarify the findings that HOMA-IR appears associated with a nontrivial risk for AD in midlife. Like I tell my audiences--the plural of anecdote is data.
Picture
So what can you do?
  • Stop eating sugar (you can mail me the donuts)
  • Join the newsletter
  • Share or like this post
  • Look around at previous posts
  • Connect on twitter or linkedin
  • Write a comment
  • Make a donation over on the side-bar -->
  • Browse the writer resources
  • Stay tuned for updates on the developing book
  • Visit my other blog, Data and Donuts
Picture
Many of you have written about the curated resources/library I am creating. Here is a new one that just made my list of books I have to read. The Man Who Wasn't There, describes how memory evolves with a distorted sense of a narrative sense. 

You can head over to the collection to see what else is new or preview the book over at Amazon. If you finish the book before I do I would love to hear what you think. As a quick aside, I went to the estate sale of Maya Angelou today nearby in Winston Salem, NC. Her home library was incredibly extensive. I found a book on Chaucer's Modern Essays in Criticism, Walden by Thoreau, and a few others that I immediately added to my collection. Honestly I could have spent my entire day in that room. You can tell so much about a person's mind by looking at their books.


Comments are closed.
    Picture

    Bonny

    A data analyst focuses the lens on the evolution of Alzheimer's Disease as a diagnosis into a billion dollar healthcare juggernaut

    Sign up for newsletter:

    Categories

    All
    Alzheimer's Disease
    Blog
    Medical Writer
    WHCOA

    ADTB remains a labor of love. It honors my dad and his journey with Alzheimer's disease.

    ​I spend quite a bit of time traveling and researching and hope to publish an expanded discussion of many of these insights.

    If you are able to and indeed benefit from my efforts I would appreciate your donation to keep the site ad-free and relevant.

    How about enough for a coffee? Any amount is appreciated. Thank you!
    Follow our blog about the intersection of health policy, economics, and clinical medicine.
    Picture
Powered by Create your own unique website with customizable templates.